44 related articles for article (PubMed ID: 38738521)
1. Complementary value of molecular analysis to expert review in refining classification of uncommon soft tissue tumors.
Suurmeijer AJH; Dickson BC; Antonescu CR
Genes Chromosomes Cancer; 2024 Jan; 63(1):e23196. PubMed ID: 37702439
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Genomic Profiling Alters Clinical Diagnoses in a Significant Fraction of Tumors Suspicious of Sarcoma.
Öfverholm I; Wallander K; Haglund C; Chellappa V; Wejde J; Gellerbring A; Wirta V; Renevey A; Caceres E; Tsagkozis P; Mayrhofer M; Papakonstantinou A; Linder-Stragliotto C; Bränström R; Larsson O; Lindberg J; Lin Y; Haglund de Flon F
Clin Cancer Res; 2024 Jun; 30(12):2647-2658. PubMed ID: 38573684
[TBL] [Abstract][Full Text] [Related]
3. Update on immunohistochemistry in bone and soft tissue tumors: Cost-effectively replacing molecular testing with immunohistochemistry.
Wakefield C; Hornick JL
Hum Pathol; 2024 May; 147():58-71. PubMed ID: 38135060
[TBL] [Abstract][Full Text] [Related]
4. Novel THBS1::IGF1R fusion in myopericytic tumour.
Kato K; Yamashita K; Dobashi A; Togashi Y; Baba S; Ae K; Matsumoto S; Takeuchi K
Histopathology; 2024 Jul; 85(1):197-201. PubMed ID: 38576274
[No Abstract] [Full Text] [Related]
5. Recurrent and novel fusions detected by targeted RNA sequencing as part of the diagnostic workflow of soft tissue and bone tumours.
Zago Baltazar R; Claerhout S; Vander Borght S; Spans L; Sciot R; Schöffski P; Hompes D; Sinnaeve F; Wafa H; Renard M; van den Hout MF; Vernemmen A; Libbrecht L; De Roo AK; Mazzeo F; van Marcke C; Deraedt K; Bourgain C; Vanden Bempt I
J Pathol Clin Res; 2024 May; 10(3):e12376. PubMed ID: 38738521
[TBL] [Abstract][Full Text] [Related]
6. Expanding the molecular signatures of malignant ossifying fibromyxoid tumours with two novel gene fusions: PHF1::FOXR1 and PHF1::FOXR2.
Srivastava P; Zilla ML; Naous R; Marker D; Khoshnoodi P; Burgess M; Herradura A; Wu J; Surrey LF; John I
Histopathology; 2023 May; 82(6):946-952. PubMed ID: 36648026
[TBL] [Abstract][Full Text] [Related]
7. Distinctive Nested Glomoid Neoplasm: Clinicopathologic Analysis of 20 Cases of a Mesenchymal Neoplasm With Frequent GLI1 Alterations and Indolent Behavior.
Papke DJ; Dickson BC; Oliveira AM; Sholl LM; Fletcher CDM
Am J Surg Pathol; 2023 Jan; 47(1):12-24. PubMed ID: 36395474
[TBL] [Abstract][Full Text] [Related]
8. Targeted RNA sequencing for upfront analysis of actionable driver alterations in non-small cell lung cancer.
Claerhout S; Lehnert S; Vander Borght S; Spans L; Dooms C; Wauters E; Vansteenkiste J; Weynand B; Deraedt K; Bourgain C; Vanden Bempt I
Lung Cancer; 2022 Apr; 166():242-249. PubMed ID: 35378489
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of an RNA sequencing panel for gene fusions in soft tissue sarcoma.
Hu W; Yuan L; Zhang X; Ni Y; Hong D; Wang Z; Li X; Ling Y; Zhang C; Deng W; Tian M; Ding R; Song C; Li J; Zhang X
Cancer Sci; 2022 May; 113(5):1843-1854. PubMed ID: 35238118
[TBL] [Abstract][Full Text] [Related]
10. FusionGDB 2.0: fusion gene annotation updates aided by deep learning.
Kim P; Tan H; Liu J; Lee H; Jung H; Kumar H; Zhou X
Nucleic Acids Res; 2022 Jan; 50(D1):D1221-D1230. PubMed ID: 34755868
[TBL] [Abstract][Full Text] [Related]
11. Clinical Implications of a Targeted RNA-Sequencing Panel in the Detection of Gene Fusions in Solid Tumors.
Sun L; McNulty SN; Evenson MJ; Zhu X; Robinson JA; Mann PR; Duncavage EJ; Pfeifer JD
J Mol Diagn; 2021 Dec; 23(12):1749-1760. PubMed ID: 34562614
[TBL] [Abstract][Full Text] [Related]
12. Optimized workflow for digitalized FISH analysis in pathology.
Chea V; Pleiner V; Schweizer V; Herzog B; Bode B; Tinguely M
Diagn Pathol; 2021 May; 16(1):42. PubMed ID: 33975608
[TBL] [Abstract][Full Text] [Related]
13. Novel morphologic findings in PLAG1-rearranged soft tissue tumors.
Logan SJ; Schieffer KM; Conces MR; Stonerock E; Miller AR; Fitch J; LaHaye S; Voytovich K; McGrath S; Magrini V; White P; Wilson RK; Mardis ER; Cottrell CE; Koo SC
Genes Chromosomes Cancer; 2021 Aug; 60(8):577-585. PubMed ID: 33893698
[TBL] [Abstract][Full Text] [Related]
14. Context-dependent roles of YAP/TAZ in stem cell fates and cancer.
LeBlanc L; Ramirez N; Kim J
Cell Mol Life Sci; 2021 May; 78(9):4201-4219. PubMed ID: 33582842
[TBL] [Abstract][Full Text] [Related]
15. YAP1 and its fusion proteins in cancer initiation, progression and therapeutic resistance.
Szulzewsky F; Holland EC; Vasioukhin V
Dev Biol; 2021 Jul; 475():205-221. PubMed ID: 33428889
[TBL] [Abstract][Full Text] [Related]
16. Head and neck rhabdomyosarcoma with TFCP2 fusions and ALK overexpression: a clinicopathological and molecular analysis of 11 cases.
Xu B; Suurmeijer AJH; Agaram NP; Zhang L; Antonescu CR
Histopathology; 2021 Sep; 79(3):347-357. PubMed ID: 33382123
[TBL] [Abstract][Full Text] [Related]
17. The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives.
Sbaraglia M; Bellan E; Dei Tos AP
Pathologica; 2021 Apr; 113(2):70-84. PubMed ID: 33179614
[TBL] [Abstract][Full Text] [Related]
18. The 2020 WHO Classification of Tumors of Soft Tissue: Selected Changes and New Entities.
Choi JH; Ro JY
Adv Anat Pathol; 2021 Jan; 28(1):44-58. PubMed ID: 32960834
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
